Asset Details
Do you wish to reserve the book?
In vitro selection of cyclized, glycosylated peptide antigens that tightly bind HIV high mannose patch antibodies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In vitro selection of cyclized, glycosylated peptide antigens that tightly bind HIV high mannose patch antibodies
Do you wish to request the book?
In vitro selection of cyclized, glycosylated peptide antigens that tightly bind HIV high mannose patch antibodies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In vitro selection of cyclized, glycosylated peptide antigens that tightly bind HIV high mannose patch antibodies
2025
Overview
selection is typically limited to discovery of peptides, proteins and nucleic acids. Given the importance of carbohydrate-protein interactions in diverse areas of biology including cell adhesion/recognition, immunoregulation and host-pathogen interactions, directed-evolution-based methods for discovery of potent glycoligands are greatly needed. We have previously reported a method for
selection of glycopeptides that combines mRNA display, alkynyl amino acid incorporation, and CuAAC \"click\" glycosylation. Herein, we describe extensions of this method that incorporate chemical cyclization, removal of N-terminal glycosylation sites and next-generation sequencing; as an approach to HIV immunogen design, we have then used this method to develop mimics of the High Mannose Patch (HMP), which is the region on HIV envelope protein gp120 most commonly targeted by HIV broadly neutralizing antibodies (bnAbs). We prepared libraries of 10
glycopeptides about 50 amino acids in length, containing variable numbers of high mannose (Man
GlcNAc
) glycans and cyclization at varied sites. We performed selections to obtain binders of HIV bnAbs PGT128, PGT122, and gl-PGT121, a germline precursor of PGT122, and prepared numerous glycopeptide hits by chemical synthesis. Selected glycopeptides in some cases bound very tightly to their target HIV bnAb, e.g., with a
as low as 0.5 nM for PGT128. These glycopeptides are of interest as immunogens and tools for HIV vaccine design.
Publisher
Cold Spring Harbor Laboratory
Subject
